XML 82 R113.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Condensed Consolidating Financials - Schedule of Supplemental Condensed Consolidating Statements of Comprehensive (Loss) Income (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Sep. 27, 2014
Jun. 28, 2014
Mar. 29, 2014
Dec. 28, 2013
Sep. 28, 2013
Jun. 29, 2013
Mar. 30, 2013
Dec. 29, 2012
Sep. 27, 2014
Sep. 28, 2013
Sep. 29, 2012
Condensed Financial Statements, Captions [Line Items]                      
Net income (loss) $ 28.2 [1] $ 11.3 [1] $ (16.8) [1] $ (5.4) [1] $ (1,113.9) [2] $ (11.0) [2] $ (51.1) [2] $ 3.1 [2] $ 17.3 $ (1,172.8) $ (73.6)
Changes in foreign currency translation adjustment                 (13.3) 1.4 6.2
Changes in unrealized holding gains and losses on available-for-sale securities                 (3.2) 12.1 0.1
Adjustment to minimum pension liability, net                 (1.3) 0.1 (1.5)
Comprehensive loss                 (0.5) (1,159.2) (68.8)
Eliminations [Member]
                     
Condensed Financial Statements, Captions [Line Items]                      
Net income (loss)                 157.8 1,127.0 (34.7)
Changes in foreign currency translation adjustment                 0 0 0
Changes in unrealized holding gains and losses on available-for-sale securities                 0 0 0
Adjustment to minimum pension liability, net                 0 0 0
Comprehensive loss                 157.8 1,127.0 (34.7)
Parent/Issuer [Member]
                     
Condensed Financial Statements, Captions [Line Items]                      
Net income (loss)                 17.3 (1,172.8) (73.6)
Changes in foreign currency translation adjustment                 0 0 0.8
Changes in unrealized holding gains and losses on available-for-sale securities                 0 0 0
Adjustment to minimum pension liability, net                 0 0 0
Comprehensive loss                 17.3 (1,172.8) (72.8)
Guarantor Subsidiaries [Member]
                     
Condensed Financial Statements, Captions [Line Items]                      
Net income (loss)                 (103.9) (1,113.9) 37.4
Changes in foreign currency translation adjustment                 0 0.7 (0.5)
Changes in unrealized holding gains and losses on available-for-sale securities                 (3.2) 12.1 0.1
Adjustment to minimum pension liability, net                 0 0 0
Comprehensive loss                 (107.1) (1,101.1) 37.0
Non-Guarantor Subsidiaries [Member]
                     
Condensed Financial Statements, Captions [Line Items]                      
Net income (loss)                 (53.9) (13.1) (2.7)
Changes in foreign currency translation adjustment                 (13.3) 0.7 5.9
Changes in unrealized holding gains and losses on available-for-sale securities                 0 0 0
Adjustment to minimum pension liability, net                 (1.3) 0.1 (1.5)
Comprehensive loss                 $ (68.5) $ (12.3) $ 1.7
[1] Net loss in the first quarter of fiscal 2014 included restructuring charges of $18.4 million and debt extinguishment loss of $2.9 million. Net loss in the second quarter of fiscal 2014 included an impairment charge related to the MRI breast coils product line of $28.6 million, restructuring charges of $11.6 million and a debt extinguishment loss of $4.4 million. Net income in the third quarter of fiscal 2014 included restructuring charges of $6.7 million. Net income in the fourth quarter of fiscal 2014 included restructuring and divestiture charges of $15.1 million and a $5.1 million IPR&D charge.
[2] Net income in the first quarter of fiscal 2013 included a gain on the sale of intellectual property of $53.9 million. Net loss in the second quarter of fiscal 2013 included restructuring charges of $12.5 million and a debt extinguishment loss of $3.2 million. Net loss in the third quarter of fiscal 2013 included restructuring charges of $6.7 million. Net loss in the fourth quarter of fiscal 2013 included a goodwill impairment charge of $1.1 billion, restructuring charges of $9.7 million and a debt extinguishment loss of $6.0 million.